Anika Therapeutics Inc. Common Stock (NASDAQ: ANIK) last traded at $21.78, up 2.06% on the session. The quote above updates while this page is open; the figures below are drawn from Anika Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Anika Therapeutics Inc. Common Stock trades on NASDAQ under the ticker ANIK. Its market capitalisation is $291.48 million.
Valuation measures for Anika Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $291.48M |
|---|---|
| Price / sales | 2.42 |
| Price / book | 2.12 |
| Beta | 0.73 |
Trailing-twelve-month figures tagged in Anika Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $120.65M |
|---|---|
| Net income (TTM) | -$3.78M |
| EPS (TTM) | -$0.270 |
| Gross margin | 62.16% |
| Operating margin | -4.24% |
| Return on equity | -2.76% |
| Cash | $38.41M |
Range and volume for ANIK over the past 52 weeks.
| 52-week high | $22.88 |
|---|---|
| 52-week low | $8.37 |
| Volume | 340.4K |
| Average volume | 90.8K |
| Previous close | $21.34 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.